Saudi German Health, the private hospital network operated by the Tadawul-listed Middle East Healthcare Company, has named two of its independent directors to the most senior positions on its board. Abdulaziz Al-Anazi has been appointed Chairman of the Board of Directors, and Dr Ahmad Alali has been appointed Vice Chairman.
The company disclosed the decisions in a statement to the Saudi Exchange (Tadawul) on 16 July 2026, reporting resolutions its board had adopted at a meeting held the previous day. Both Al-Anazi and Alali serve on the board as independent directors, and their elevation places independent members in the two roles that set the board's agenda and oversee its work. The same set of resolutions also approved the appointment of a new secretary to the board.
The chairman and vice chairman roles are governance positions rather than executive ones: they lead the board and its oversight of the company, which remains distinct from the day-to-day management run by the executive team. Concentrating those responsibilities in independent directors is intended to strengthen the board's ability to supervise management on behalf of all shareholders.
Placing independent directors in the chair and vice-chair roles is consistent with Saudi corporate governance expectations, which encourage listed companies to give independent members a leading voice at the top of the board. For a healthcare operator whose shares trade publicly, the composition of board leadership carries weight with regulators and shareholders alike, shaping how the company is supervised and how major decisions are taken.
Middle East Healthcare Company operates under the Saudi German Health brand and is among the larger private healthcare providers in Saudi Arabia and the wider region, running a network of hospitals that deliver a broad range of clinical services across several cities. The Saudi German Hospitals brand has operated in the Kingdom for years and is among the recognised names in regional private healthcare. As a company listed on the Saudi Exchange, its board appointments are disclosed to the market through official Tadawul filings, giving investors a formal record of changes in its leadership.
The change in board leadership comes as Saudi Arabia continues to expand private healthcare capacity under its Vision 2030 economic programme, which has drawn investment into hospitals, insurance and specialised care. Governance at the country's listed healthcare groups has drawn closer attention from investors and regulators as the sector grows, making the appointment of a new chairman and vice chairman a notable marker of how Saudi German Health intends to steer its next phase.
